Table 2.
Clinical events and laboratory findings during the postoperative period.
| S group (n = 78) |
C group (n = 96) |
P | |
|---|---|---|---|
| Time to extubation (min) | 6 ± 3 | 8 ± 3 | 0.000 |
| Delayed extubation | 4 | 5 | 1.000 |
| Pulmonary complications | 16 | 19 | 1.000 |
| Hypoxia | 18 | 41 | 0.010 |
| Admission to ICU | 16 | 15 | 0.431 |
| ICU stay duration (days) | 0.7 ± 2.0 | 0.5 ± 2.2 | 0.481 |
| Hospital stay duration (days) | 17 (14–20) | 16 (14–21) | 0.816 |
| Hematocrit (%) | 29 ± 5 | 29 ± 5 | 0.272 |
| Total protein (g/dL) | 4.8 ± 1.1 | 4.8 ± 1.2 | 0.995 |
| Albumin (g/dL) | 2.5 ± 0.4 | 2.5 ± 0.8 | 0.567 |
| Glucose (mg/dL) | 140 ± 43 | 143 ± 56 | 0.708 |
| AST (IU/L) | 31 ± 15 | 33 ± 20 | 0.409 |
| ALT (IU/L) | 30 ± 51 | 20 ± 15 | 0.103 |
| Creatinine (mg/dL) | 0.7 ± 0.3 | 0.8 ± 0.5 | 0.121 |
| HS-CRP (mg/dL) | 3.4 ± 4.3 | 2.5 ± 3.3 | 0.150 |
Data are numbers of patients, mean ± standard deviation, or median (25%–75%).
S group, sugammadex group; C group, conventional cholinesterase inhibitor group; hypoxia, oxygen saturation <95% up to 24 hours postoperatively; ICU, intensive care unit; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HS-CRP, high- sensitivity C-reactive protein.